Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid.
about
The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-upNeuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke.Association between total-Tau and brain atrophy one year after first-ever stroke.APP as a Protective Factor in Acute Neuronal Insults.Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy.Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.Prognostic value of cerebrospinal fluid free fatty acid levels in patients with acute ischemic stroke.Hippocampal complex atrophy in poststroke and mild cognitive impairmentCerebral white matter lesions - associations with Aβ isoforms and amyloid PETCSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease.Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis.Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's diseaseCSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease.Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus.White matter hyperintensity microstructure in amyloid dysmetabolism.Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease.Low Cerebrospinal Fluid Aβ42 and Aβ40 are Related to White Matter Lesions in Cognitively Normal Elderly.
P2860
Q30980369-6EA2138E-2EDC-4D95-AD74-E081CFD15B98Q33689233-430B06B5-E0CE-4D22-83DC-3715D0F13340Q33767858-05228432-B355-41DE-92B5-AB123A80C83BQ34551487-14729022-B100-4950-8A26-E76718FBF86BQ34632746-68B7CCC6-3BBF-49B2-9C92-D3FB7AD3E269Q35123209-AF82EB26-68C4-403A-9BBE-B65FAE12A656Q35847664-1ADB7EEA-6943-4C45-B205-71EDC8F13C9BQ36254312-12E86FA8-BC9C-49F8-9827-8DC6F993D866Q36559869-07246323-BE53-4D02-B687-6DA4CCDF2F80Q36639655-51EFDF3B-ED24-4287-8629-1D0D7D75CC20Q36674545-1C39667C-FA55-486D-BEF1-6A89FDBED997Q36718213-DB30881A-7323-44C0-B225-9F6D866432FFQ38012590-169E421B-DA8B-485E-B80D-8C2786A7523DQ38603309-90595D99-3563-418C-8FF8-4BBE32403D13Q38929253-F4DE83E7-6321-432A-B8E1-80AF58B1E1E3Q39098473-922C9D5E-01D8-4504-9688-C1E0680EE189Q46573885-A6B15A7E-11AA-4B7B-B40F-0BA2C9342EE5Q47147506-F3F7D04D-37FD-4CD0-BFA1-EC49B80E76BFQ48650878-A773515B-662C-4D61-AF46-A5223141C8BFQ55028222-54B8A5FA-7CB0-4A92-A99D-439C11040F50
P2860
Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Effects of cerebrovascular dis ...... olites in cerebrospinal fluid.
@en
type
label
Effects of cerebrovascular dis ...... olites in cerebrospinal fluid.
@en
prefLabel
Effects of cerebrovascular dis ...... olites in cerebrospinal fluid.
@en
P2093
P2860
P50
P356
P1476
Effects of cerebrovascular dis ...... olites in cerebrospinal fluid.
@en
P2093
Lisbeth Johnsen
Per Selnes
Ramune Grambaite
Tormod Fladby
Vidar Stenset
P2860
P2888
P356
10.1186/1743-8454-7-10
P577
2010-07-30T00:00:00Z
P5875
P6179
1025897250